Principal Investigator
Carlos Singer
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20230370
Clinical Trial Summary
A Phase 2, double-blind, placebo-controlled, parallel-group study to assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and potential efficacy of multiple doses of ONO-2808 in patients with Multiple System Atrophy (MSA)
Phase
Phase II
Funding Agency/Sponsor
Industry
Disease
Other
Contact Information
Study Contact
Lucila Hernandez
Phone Number
+1 (305) 2431160
Email
lmh245@miami.edu